Home Healthcare Medical Devices Connected Drug Delivery Devices Market

Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Standalone Components & Software, Integrated Devices), By Device Type (Inhalers, Pen and Auto-injectors, Prefilled Syringes, Wearable Injectors), By Application (Asthma & COPD, Diabetes, Autoimmune Diseases, Hormonal Disorders), By End User (Homecare Settings, Hospitals & Clinics, Specialty Care Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 24, 2026 | Author: Dhanashri Chandgude | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Connected Drug Delivery Devices Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Standalone Components & Software
    2. Integrated Devices
  2. Connected Drug Delivery Devices Market, By Device Type 2022-2034 (USD MILLION/ Units)
    1. Inhalers
    2. Pen and Auto-injectors
    3. Prefilled Syringes
    4. Wearable Injectors
  3. Connected Drug Delivery Devices Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Asthma & COPD
    2. Diabetes
    3. Autoimmune Diseases
    4. Hormonal Disorders
  4. Connected Drug Delivery Devices Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Homecare Settings
    2. Hospitals & Clinics
    3. Specialty Care Centers
  5. Regional Connected Drug Delivery Devices Market
    1. North America
      1. North America Connected Drug Delivery Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Standalone Components & Software
        2. Integrated Devices
      2. North America Connected Drug Delivery Devices Market By Device Type 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Pen and Auto-injectors
        3. Prefilled Syringes
        4. Wearable Injectors
      3. North America Connected Drug Delivery Devices Market By Application 2022-2034 (USD MILLION/ Units)
        1. Asthma & COPD
        2. Diabetes
        3. Autoimmune Diseases
        4. Hormonal Disorders
      4. North America Connected Drug Delivery Devices Market By End User 2022-2034 (USD MILLION/ Units)
        1. Homecare Settings
        2. Hospitals & Clinics
        3. Specialty Care Centers
      5. U.S.
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      6. Canada
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
    2. Europe
      1. Europe Connected Drug Delivery Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Standalone Components & Software
        2. Integrated Devices
      2. Europe Connected Drug Delivery Devices Market By Device Type 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Pen and Auto-injectors
        3. Prefilled Syringes
        4. Wearable Injectors
      3. Europe Connected Drug Delivery Devices Market By Application 2022-2034 (USD MILLION/ Units)
        1. Asthma & COPD
        2. Diabetes
        3. Autoimmune Diseases
        4. Hormonal Disorders
      4. Europe Connected Drug Delivery Devices Market By End User 2022-2034 (USD MILLION/ Units)
        1. Homecare Settings
        2. Hospitals & Clinics
        3. Specialty Care Centers
      5. U.K.
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      6. Germany
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      7. France
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      8. Spain
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      9. Italy
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      10. Russia
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      11. Nordic
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      12. Benelux
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      13. Rest of Europe
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
    3. APAC
      1. APAC Connected Drug Delivery Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Standalone Components & Software
        2. Integrated Devices
      2. APAC Connected Drug Delivery Devices Market By Device Type 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Pen and Auto-injectors
        3. Prefilled Syringes
        4. Wearable Injectors
      3. APAC Connected Drug Delivery Devices Market By Application 2022-2034 (USD MILLION/ Units)
        1. Asthma & COPD
        2. Diabetes
        3. Autoimmune Diseases
        4. Hormonal Disorders
      4. APAC Connected Drug Delivery Devices Market By End User 2022-2034 (USD MILLION/ Units)
        1. Homecare Settings
        2. Hospitals & Clinics
        3. Specialty Care Centers
      5. China
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      6. Korea
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      7. Japan
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      8. India
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      9. Australia
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      10. Taiwan
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      11. South East Asia
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      12. Rest of Asia-Pacific
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
    4. Middle East and Africa
      1. Middle East and Africa Connected Drug Delivery Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Standalone Components & Software
        2. Integrated Devices
      2. Middle East and Africa Connected Drug Delivery Devices Market By Device Type 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Pen and Auto-injectors
        3. Prefilled Syringes
        4. Wearable Injectors
      3. Middle East and Africa Connected Drug Delivery Devices Market By Application 2022-2034 (USD MILLION/ Units)
        1. Asthma & COPD
        2. Diabetes
        3. Autoimmune Diseases
        4. Hormonal Disorders
      4. Middle East and Africa Connected Drug Delivery Devices Market By End User 2022-2034 (USD MILLION/ Units)
        1. Homecare Settings
        2. Hospitals & Clinics
        3. Specialty Care Centers
      5. UAE
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      6. Turkey
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      7. Saudi Arabia
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      8. South Africa
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      9. Egypt
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      10. Nigeria
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      11. Rest of MEA
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
    5. LATAM
      1. LATAM Connected Drug Delivery Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Standalone Components & Software
        2. Integrated Devices
      2. LATAM Connected Drug Delivery Devices Market By Device Type 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Pen and Auto-injectors
        3. Prefilled Syringes
        4. Wearable Injectors
      3. LATAM Connected Drug Delivery Devices Market By Application 2022-2034 (USD MILLION/ Units)
        1. Asthma & COPD
        2. Diabetes
        3. Autoimmune Diseases
        4. Hormonal Disorders
      4. LATAM Connected Drug Delivery Devices Market By End User 2022-2034 (USD MILLION/ Units)
        1. Homecare Settings
        2. Hospitals & Clinics
        3. Specialty Care Centers
      5. Brazil
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      6. Mexico
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      7. Argentina
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      8. Chile
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      9. Colombia
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
      10. Rest of LATAM
        1. Standalone Components & Software
        2. Integrated Devices
        3. Inhalers
        4. Pen and Auto-injectors
        5. Prefilled Syringes
        6. Wearable Injectors
        7. Asthma & COPD
        8. Diabetes
        9. Autoimmune Diseases
        10. Hormonal Disorders
        11. Homecare Settings
        12. Hospitals & Clinics
        13. Specialty Care Centers
Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com
custom reports
Need a Tailored Report?
80% of our existing clients ask for tailored reports.
Request Customization

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.